Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-05

Clinical Trial Update: Energetics and Glutamate in Schizophrenia

View source ↗

Summary

An ongoing clinical trial funded by King's College London is examining brain energetics and glutamate signaling in schizophrenia. The study is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: King's College London | Conditions: Schizophrenia | Status: RECRUITING